Tommaso Giarratano

7PUBLICATIONS
54CO-AUTHORS
Tumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 17, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer.

|Sep 04, 2025
Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial.

Federica Miglietta, Manon De Graaf, Claudio Vernieri

|Apr 24, 2024
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer.

Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci

|Sep 12, 2023
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in Italy.

Fabio Girardi, Sabrina Marini, Francesca Porra

|Mar 20, 2023
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Grazia Vernaci, Edoardo Vincenzo Savarino, Ilaria Patuzzi

|Oct 20, 2021
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial.

Maria Vittoria Dieci, Valentina Guarneri, Anna Tosi

Pageof 2

Frequent Collaborators

6 joint publications

Valentina Guarneri

5 joint publications

Maria Vittoria Dieci

5 joint publications

Gaia Griguolo

4 joint publications

Grazia Vernaci